Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by ilvmyt5son Dec 19, 2020 8:12pm
678 Views
Post# 32148105

RE:RE:A rainy Saturday

RE:RE:A rainy SaturdayCramer screaming canopy! canopy! when he was commenting on the Tilphria deal on CNBC was so boomer.lol Never been able to find out why you have to pay a $25 dollar premium for WEED. They are like the 5th largest LP now????wtf


arblines wrote:
Maybe by the time the deal closes the market will realize Canopy is not with 2X to 3X these companies. Once the merger is completed, the new TLRY will sell the most product, have the most profit, US based, billion backed, Bob Marley branded, ties with Budweiser, and Norvaris. Aphria is basically a wholesaler that needs what TLRY has. TLRY could be 30$ plus just to match WEED''s MCap. Just playing Devil's advocate to your Devil's advocate. I see lots of upside. ACB would have been a disaster. I have been with APHA for four years through it all and feel this is the best acquisition they have made... Other than CC Pharma.


<< Previous
Bullboard Posts
Next >>